intellectual property

TRIPS flexibilities under threat from investment disputes: a closer look at Canada’s “win” against Eli Lilly

IP Watch | 28-Apr-2017

Although Canada won in a unanimous decision, the ruling does not, however, guarantee domestic discretion going forward, contrary to the suggestion of some.

keywords: Canada , health , intellectual property , investor-state disputes | ISDS , US

Treating intellectual property as an investment, and subjecting it to treaty arbitration, can have undesirable impact

Economic Times | 19-Apr-2017

Free trade agreements tend to treat intellectual property as an investment made by investor corporations, allowing private investment disputes to be raised against the host country.

keywords: India , intellectual property , investment | BITs , investor-state disputes | ISDS , RCEP

Accord commercial UE-Mexique en révision : l’UE veut expédier les négociations malgré les risques

AITEC | 18-Apr-2017

L’objectif de ces nouvelles négociations est d’amener l’instrument commercial liant l’UE et le Mexique au niveau des accords commerciaux comme le CETA, référence désormais brandie par la Commission européenne pour l’ensemble de ses négociations futures.

keywords: EU , intellectual property , investor-state disputes | ISDS , Mexico , public procurement , services , TBT

El TLCAN 2.0 es acerca del control, no del libre comercio

El Financiero | 14-Apr-2017

Un tema que no ha sido analizado a profundidad son las nuevas disposiciones que serán agregadas al texto del tratado en materia de medio ambiente, laboral, sindical, propiedad intelectual, entre otros.

keywords: CPTPP , intellectual property , investor-state disputes | ISDS , NAFTA | USMCA

Novartis pointé du doigt en Colombie

AGEFI | 13-Apr-2017

Le géant bâlois est accusé d’avoir "menacé" le ministère colombien du Commerce et de l’Industrie de recourir à un tribunal d’arbitrage international.

keywords: Colombia , intellectual property , investor-state disputes | ISDS , medicines , Switzerland

Compulsory licensing in Colombia: Leaked documents show aggressive lobbying by Novartis

Public Eye | 12-Apr-2017

Confidential documents obtained by Public Eye show that Novartis has threatened Colombia with international investment arbitration under its BIT with Switzerland to avoid the issuance of a compulsory license

keywords: Colombia , corporate interests , intellectual property , investor-state disputes | ISDS , leaks , medicines , Switzerland

Gilead Pharma corp withdraws investment arbitration after Ukraine agrees to settlement of dispute over monopoly rights to market anti-viral drug

IA Reporter | 5-Apr-2017

Ukraine has settled a dispute with American pharmaceutical company Gilead Sciences Inc., following the company’s pursuit of legal remedies in both domestic courts and via investment arbitration.

keywords: intellectual property , investor-state disputes | ISDS , medicines , Ukraine , US

Pharmaceutical giant threatens to drag Government before corporate tribunal

Public Citizen | 1-Apr-2017

Novartis battle against Colombian Government highlights the threats to public health posed by the outrageous investor-state dispute settlement regime and bad “trade” deals.

keywords: Colombia , health , intellectual property , investor-state disputes | ISDS , Switzerland

Tribunal dismisses Eli Lilly’s NAFTA challenge on promise utility doctrine

Lexology | 27-Mar-2017

The Tribunal found that Eli Lilly had failed to demonstrate that the promise doctrine constitutes a fundamental or dramatic change in the utility requirement under Canadian patent law or that the promise doctrine is arbitrary and/or discriminatory.

keywords: Canada , intellectual property , investor-state disputes | ISDS , medicines , NAFTA | USMCA , US